CP 331
Alternative Names: CP 6; CP 7Latest Information Update: 08 Jul 1998
At a glance
- Originator Zeria
- Class Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 08 Jul 1998 Discontinued-Preclinical for Rheumatoid arthritis in Japan (PO)
- 19 Feb 1997 Preclinical development for Rheumatoid arthritis in Japan (PO)